Luther King Capital Management (LKCM)’s iShares Biotechnology ETF IBB Stock Holding History

Luther King Capital Management (LKCM)’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-5,490	Closed	-$477K	–	520
2016 Q1	$477K	Hold	5,490	–	–	﹤0.01%	403
2015 Q4	$619K	Buy	5,490 +540	+11%	+$58.6K	0.01%	394
2015 Q3	$500K	Hold	4,950	–	–	﹤0.01%	415
2015 Q2	$609K	Buy	+4,950	New	+$593K	0.01%	413

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Societe Generale $14.1B AUM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Luther King Capital Management (LKCM)'s IBB Position: Q2 2016 in Review

Luther King Capital Management (LKCM) sold out of iShares Biotechnology ETF (IBB) in Q2 2016, closing a stake of 5,490 shares — an estimated $477K sold.

Luther King Capital Management (LKCM) first reported a position in IBB in Q2 2015 and held it in 4 quarters. The position peaked at $619K in Q4 2015. 429 funds tracked by Wall St. Rank hold IBB as of Q2 2016.

Luther King Capital Management (LKCM) reported no remaining iShares Biotechnology ETF position as of Q2 2016 after selling out during the quarter.
Luther King Capital Management (LKCM) sold 5,490 iShares Biotechnology ETF shares in Q2 2016, an estimated $477K.
Luther King Capital Management (LKCM) first reported a position in iShares Biotechnology ETF in Q2 2015 and held it in 4 quarters.
Luther King Capital Management (LKCM)'s iShares Biotechnology ETF position peaked at $619K in Q4 2015.
429 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2016.

Based on Luther King Capital Management (LKCM)'s 13F filing for Q2 2016, filed 11 Aug 2016.